June 7th Flashcards
Standard DKA tx
IV fluids, IV insulin and K+ replacement
DKA DDx
Infection Serious medical illness (MI/Stroke) Nonadherence to insulin Drugs/Alcohol Dehydration
Standard tx for DM1
Insulin
Standard Tx for DM2
Low carb diet
Weight loss
Oral hyperglycemic drugs (Metformin)
Insulin
DM 2 Drug with lactic acidosis risk
Metformin
DM 2 Drug with most common side effect hypoglycemia
Sulfonylureas
DM 2 Drug recommend first line
Metformin
DM 2 Drug not safe in symptomatic CHF
TZDs (Pioglitazone & Rosiglitazone)
DM 2 Drug not to use in abnormal kidney function
Metformin
SGLT-2 inhibitors
TZD (Pioglitazone & Rosiglitazone)
DM 2 Drug weight neutral/weight loss
Metformin
GLP-1 analog (Exenatide, Lirafgutide)
SGLT-2 inhibitor (Canaglifozin)
DPP-4 inhibitors (Linagliptin, Saxagliptin, Sitagliptin)
DM 2 Drug metabolized by liver can be used in renal dysfunction
TZDs
DM 2 Drug MOA of closing K channel on B cells > cell deploy > Ca influx > Insulin release
Sulfonylureas
Meglitinides
DM 2 Drug MOA inhibiting alpha glucosidase at intestinal brush border
Acarbose
Miglitol
DM 2 Drug agonist at PPAR-y»_space; improved target cell response to insulin
TZD
DM 2 Drug decreased hepatic gluconeogneeis
Metformin TZDs
DM 2 Drug decreased glucose resorb in renal tubules
SGLT-2 inhibitors
DM 2 Drug used in organ failure
DDP-4 inhibitors